Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Restoring our ubiquitination machinery to overcome resistance in cancer therapy

Oncoscience(2024)10.18632/oncoscience.600Source: DataRank Database

Restoring our ubiquitination machinery to overcome resistance in cancer therapy is a research paper published in Oncoscience (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.50)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Ping Mu ORCID,Xiaoling Li ORCID

Live enrichment

PubMed:38711948 PMC:PMC11073315 OpenAlex:https://openalex.org/W4396670713

NCI NIH HHS

Grant: R01 CA288820

NCI NIH HHS

Grant: R01 CA292949

NCI NIH HHS

Grant: R37 CA258730

National Institutes of Health

Grant: 7R37CA258730-05

Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance

FWCI

0.50

Citation Percentile

0.6%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.oncoscience.us/article/600/pdf/

publisherhttps://www.oncoscience.us/article/600/pdf/

publisherhttps://www.oncoscience.us/lookup/doi/10.18632/oncoscience.600

journalhttps://doi.org/10.18632/oncoscience.600

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38711948

Fields of Study

Ubiquitin and proteasome pathwaysProtein Degradation and InhibitorsHistone Deacetylase Inhibitors Research03 medical and health sciences0302 clinical medicine

Keywords

UbiquitinCancerCancer therapyResistance (ecology)MedicineCancer researchBiologyInternal medicineGeneticsEcologyUbiquitinationAndrogen receptorProtein degradationprostate cancerProtacAntiandrogen ResistanceUbe2j1Editorial

Sustainable Development Goals

SDG 0: Zero hunger